Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Laurus Labs Ltd.
Press Release May 02 2023
Business
May 2 2023
3 min read

Press Release May 02 2023

Laurus Labs Limited has informed the Exchange regarding a press release dated May 02, 2023, titled "Laurus Labs receives USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film (ODF) drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment".

View Attachment